HBV-mediated macrophage release of matrix metalloproteinase 9 (MMP9) and IL-23 induces the blockade of binding of IFN-α to IFNAR1, which could contribute to tumor progression and angiogenesis (177, 178). The gene discussed is MMP9; the disease is neoplasm.